Immunolocalization of tissue plasminogen activator in the diabetic and nondiabetic retina and choroid.
暂无分享,去创建一个
D. S. Mcleod | G. Lutty | K. Ikeda | C. Chandler | D. Mcleod
[1] I. Nilsson,et al. On fibrinolysis in diabetes mellitus. , 2009, Acta medica Scandinavica.
[2] L V McIntire,et al. Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells. , 1989, Science.
[3] E M Kohner,et al. Long-term follow-up of retinal blood flow in diabetes using the blue light entoptic phenomenon. , 1989, The British journal of ophthalmology.
[4] R. Tripathi,et al. Distribution of tissue plasminogen activator in human and monkey eyes. An immunohistochemical study. , 1987, Ophthalmology.
[5] B. Binder,et al. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies. , 1987, The Journal of laboratory and clinical medicine.
[6] S. Pizzo,et al. Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis. , 1987, The American journal of medicine.
[7] J. Hall,et al. Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura. , 1986, The Journal of laboratory and clinical medicine.
[8] A. Kjaeldgaard,et al. In vitro stimulation of plasminogen activator release from vein walls by adrenaline. , 1986, Journal of clinical pathology.
[9] A. Larsson,et al. Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall. , 1985, Journal of clinical pathology.
[10] F. Bachmann,et al. Tissue Plasminogen Activator: Chemical and Physiological Aspects , 1984, Seminars in thrombosis and hemostasis.
[11] D. Moscatelli,et al. Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[12] H. Little. Alterations in blood elements in the pathogenesis of diabetic retinopathy. , 1981, Ophthalmology.
[13] D. Rijken,et al. Relationship between tissue plasminogen activator and the activators in blood and vascular wall. , 1980, Thrombosis research.
[14] H. Keen,et al. Haemostatic variables associated with diabetes and its complications. , 1979, British medical journal.
[15] D. Loskutoff,et al. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[16] V. N. Hegt. Relations between Activation and Inhibition of Fibrinolysis in the Walls of Human Arteries and Veins , 1977, Thrombosis and Haemostasis.
[17] I. Nilsson,et al. Diabetic Retinopathy and the Fibrinolytic System , 1975, Diabetes.
[18] M. Åberg,et al. The plasminogen activator activity of arteries and veins in diabetes mellitus. , 1975, Thrombosis research.
[19] A. Todd. The histological localisation of fibrinolysin activator. , 1959, The Journal of pathology and bacteriology.
[20] D. Collen,et al. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine. , 1987, The Journal of laboratory and clinical medicine.
[21] 石崎 良太郎,et al. ヒトTissue Plasminogen Activator(t-PA)の研究 I : 生産と精製法の検討 , 1986 .
[22] D. Wagner,et al. Von Willebrand protein binds to extracellular matrices independently of collagen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[23] P. Gaffney,et al. Some observations on the release of extrinsic and intrinsic plasminogen activators during exercise in man. , 1980, Haemostasis.